Trials / Completed
CompletedNCT03853525
A Study to Gain Information How Well Dexpanthenol Dermal Spray Helps the Skin to Recover After Laser Hair Removal in the Groin and Intimate Area
Safety and Efficacy Evaluation of the Use of Bepantol® Derma Spray After Laser Depilation in the Inguinal Region in Adult Women - 21 Days Use at Home
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Bayer · Industry
- Sex
- Female
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
In this study, researchers want to learn more about the effect of dexpanthenol dermal spray on skin recovery after a dermatological procedure for hair removal (laser depilation) in the groin and intimate area in adult women. After the hair removal procedure, participants will return within 3 weeks for 3 visits to the study center to investigate the skin condition such as redness, irritation, softness of skin and possible side effects. Study participants will also be asked about their general acceptance of dexpanthenol dermal spray.
Detailed description
The primary objective is to evaluate the efficacy of the test product to aid skin recovery after lasering depilation in the intima and inguinal region. Secondary objectives comprise clinical efficacy with respect to skin hydration, softness, vitality, appearance etc. and skin recovery, consumer judgement of product performance and acceptability, and safety.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BAY207543 (Bepanthol, Bepantol® Derma Spray) | Product is applied to one side of the inguinal region. |
| OTHER | Semisolid vaseline | Product is applied to one side of the inguinal region. |
Timeline
- Start date
- 2019-02-11
- Primary completion
- 2019-03-11
- Completion
- 2019-03-11
- First posted
- 2019-02-25
- Last updated
- 2020-03-11
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03853525. Inclusion in this directory is not an endorsement.